Browse by ["viewname_eprint_publisher" not defined]
![]() | Up a level |
- University of Regensburg (6)
- Medicine (6)
- Institut für Funktionelle Genomik (6)
- Lehrstuhl für Funktionelle Genomik (Prof. Oefner) (6)
- Institut für Funktionelle Genomik (6)
- Medicine (6)
B
Boettcher, M. and Renner, K. and Berger, R. and Mentz, K. and Thomas, S. and Cardenas-Conejo, Z. E. and Dettmer, K. and Oefner, P. J. and Mackensen, A. and Kreutz, M. and Mougiakakos, D. (2018) Immunometabolic impact of D-2HG on human T-cells. KARGER, BASEL.
H
Hammon, K. and Cardenas-Conejo, Z. E. and Dettmer, K. and Oefner, P. and Herr, W. and Renner, K. and Kreutz, M. and Thomas, S. (2017) The tumor-derived oncometabolite D-2-Hydroxyglutarate alters the immune phenotype as well as mitochondrial activity of monocyte-derived dendritic cells. KARGER, BASEL.
Holler, E. and Landfried, K. and Zhu, W. and Waldbier, M. and Schulz, U. and Ammer, J. and Holler, B. and Wolff, D. and Edinger, M. and Kreutz, M. and Andreesen, R. and Oefner, P. (2011) Reactive release of tryptophan metabolites in early complications of human stem cell transplantation indicates activation of IDO. ONKOLOGIE, 34 (Suppl6). p. 279. ISSN 0378-584X
Holler, E. and Zhu, W. and Landfried, K. and Peter, K. and Kreutz, M. and Ammer, J. and Holler, B. and Wolff, D. and Edinger, M. and Andreesen, R. and Oefner, P. (2012) Indoxyl sulfate as a marker of intestinal bacterial diversity in patients receiving allogeneic stem cell transplantation: Impact of antibiotic treatment and intestinal GvHD. ONKOLOGIE, 35 (suppl6). p. 158. ISSN 0378-584X
S
Sporrer, D. and Koestler, J. and Gessner, A. and Oefner, P. and Holler, E. (2013) The Influence of Rifaximin prophylaxis on intestinal microbiota, GvHD and infections in ASCT. KARGER, BASEL.
Strobl, C. and Henrich, F. and Singer, K. and Gronwald, W. and Bosserhoff, A. and Kreutz, M. and Poller, K. and Kremer, A. and Mackensen, A. and Aigner, M. (2015) 5 '-deoxy-5 '-methylthioadenosine suppresses human T cell function and represents a novel mechanism of tumor immune escape. KARGER, BASEL.

